SciBase Holding

Bergs Securities is proud to have acted as financial adviser to SciBase Holding AB in its SEK 80 million rights issue.

SciBase Holding is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase Holding develops, manufactures, and commercializes Nevisense, a unique point-of-care platform that combines AI and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.